This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, W. E.
Right arrow Articles by Sanders, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, W. E., Jr
Right arrow Articles by Sanders, C. C.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 04 1997, 220-241, Vol 10, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Enterobacter spp.: pathogens poised to flourish at the turn of the century

WE Sanders Jr and CC Sanders
Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 68178, USA.

Knowledge of the genus Enterobacter and its role in human disease has expanded exponentially in recent years. The incidence of infection in the hospital and the community has increased. New clinical syndromes have been recognized. Enterobacter spp. have also been implicated as causes of other syndromes that traditionally have been associated almost exclusively with more easily treatable pathogens, such as group A streptococci and staphylococci. Rapid emergence of multiple-drug resistance has been documented in individual patients during therapy and in populations and environments with strong selective pressure from antimicrobial agents, especially the cephalosporins. Therapeutic options for patients infected with multiply resistant strains have become severely limited. Carbapenems or, alternatively, fluoroquinolones are the most predictively active options, although resistance to both classes has been observed on rare occasions. Enterobacter spp. appear well adapted for survival and even proliferation as the turn of the century approaches.


This article has been cited by other articles:

  • Paauw, A., Caspers, M. P. M., Leverstein-van Hall, M. A., Schuren, F. H. J., Montijn, R. C., Verhoef, J., Fluit, A. C. (2009). Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain. Microbiology 155: 1478-1488 [Abstract] [Full Text]  
  • Marcos, M., Inurrieta, A., Soriano, A., Martinez, J. A., Almela, M., Marco, F., Mensa, J. (2008). Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. J Antimicrob Chemother 62: 397-403 [Abstract] [Full Text]  
  • Choi, S.-H., Lee, J. E., Park, S. J., Choi, S.-H., Lee, S.-O., Jeong, J.-Y., Kim, M.-N., Woo, J. H., Kim, Y. S. (2008). Emergence of Antibiotic Resistance during Therapy for Infections Caused by Enterobacteriaceae Producing AmpC {beta}-Lactamase: Implications for Antibiotic Use. Antimicrob. Agents Chemother. 52: 995-1000 [Abstract] [Full Text]  
  • Kim, K.-P., Loessner, M. J. (2008). Enterobacter sakazakii Invasion in Human Intestinal Caco-2 Cells Requires the Host Cell Cytoskeleton and Is Enhanced by Disruption of Tight Junction. Infect. Immun. 76: 562-570 [Abstract] [Full Text]  
  • Stearne, L. E. T., Goessens, W. H. F., Mouton, J. W., Gyssens, I. C. (2007). Effect of Dosing and Dosing Frequency on the Efficacy of Ceftizoxime and the Emergence of Ceftizoxime Resistance during the Early Development of Murine Abscesses Caused by Bacteroides fragilis and Enterobacter cloacae Mixed Infection. Antimicrob. Agents Chemother. 51: 3605-3611 [Abstract] [Full Text]  
  • Perez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., del Mar Tomas, M., Fernandez, A., Mallo, S., Perez, S., Molina, F., Villanueva, R., Lasa, I., Bou, G. (2007). Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate. Antimicrob. Agents Chemother. 51: 3247-3253 [Abstract] [Full Text]  
  • Masi, M., Pages, J.-M., Pradel, E. (2006). Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. J Antimicrob Chemother 57: 1223-1226 [Abstract] [Full Text]  
  • Mohan Nair, M. K., Venkitanarayanan, K. S. (2006). Cloning and Sequencing of the ompA Gene of Enterobacter sakazakii and Development of an ompA-Targeted PCR for Rapid Detection of Enterobacter sakazakii in Infant Formula. Appl. Environ. Microbiol. 72: 2539-2546 [Abstract] [Full Text]  
  • Steele, C. M., Brown, R. N., Botzler, R. G. (2005). PREVALENCES OF ZOONOTIC BACTERIA AMONG SEABIRDS IN REHABILITATION CENTERS ALONG THE PACIFIC COAST OF CALIFORNIA AND WASHINGTON, USA. J Wildl Dis 41: 735-744 [Abstract] [Full Text]  
  • Masi, M., Pages, J.-M., Villard, C., Pradel, E. (2005). The eefABC Multidrug Efflux Pump Operon Is Repressed by H-NS in Enterobacter aerogenes. J. Bacteriol. 187: 3894-3897 [Abstract] [Full Text]  
  • Schlesinger, J., Navon-Venezia, S., Chmelnitsky, I., Hammer-Munz, O., Leavitt, A., Gold, H. S., Schwaber, M. J., Carmeli, Y. (2005). Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49: 1150-1156 [Abstract] [Full Text]  
  • Jiang, X., Ni, Y., Jiang, Y., Yuan, F., Han, L., Li, M., Liu, H., Yang, L., Lu, Y. (2005). Outbreak of Infection Caused by Enterobacter cloacae Producing the Novel VEB-3 Beta-Lactamase in China. J. Clin. Microbiol. 43: 826-831 [Abstract] [Full Text]  
  • Hossain, A., Ferraro, M. J., Pino, R. M., Dew, R. B. III, Moland, E. S., Lockhart, T. J., Thomson, K. S., Goering, R. V., Hanson, N. D. (2004). Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp.. Antimicrob. Agents Chemother. 48: 4438-4440 [Abstract] [Full Text]  
  • Muller, A., Lopez-Lozano, J. M., Bertrand, X., Talon, D. (2004). Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J Antimicrob Chemother 54: 173-177 [Abstract] [Full Text]  
  • Stearne, L. E. T., van Boxtel, D., Lemmens, N., Goessens, W. H. F., Mouton, J. W., Gyssens, I. C. (2004). Comparative Study of the Effects of Ceftizoxime, Piperacillin, and Piperacillin-Tazobactam Concentrations on Antibacterial Activity and Selection of Antibiotic-Resistant Mutants of Enterobacter cloacae and Bacteroides fragilis In Vitro and In Vivo in Mixed-Infection Abscesses. Antimicrob. Agents Chemother. 48: 1688-1698 [Abstract] [Full Text]  
  • Conceicao, T., Faria, N., Pimentel, M., Soveral, G., Duarte, A., Lito, L. M., Melo Cristino, J., Salgado, M. J. (2004). New Chromosomal AmpC {beta}-Lactamase in Enterobacter cloacae. Antimicrob. Agents Chemother. 48: 1437-1437 [Full Text]  
  • Bell, J. M., Turnidge, J. D., Jones, R. N., the SENTRY Asia-Pacific Participants,, (2003). Prevalence of Extended-Spectrum {beta}-Lactamase-Producing Enterobacter cloacae in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob. Agents Chemother. 47: 3989-3993 [Abstract] [Full Text]  
  • Hoffmann, H., Roggenkamp, A. (2003). Population Genetics of the Nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol. 69: 5306-5318 [Abstract] [Full Text]  
  • Schwaber, M. J., Graham, C. S., Sands, B. E., Gold, H. S., Carmeli, Y. (2003). Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species. Antimicrob. Agents Chemother. 47: 1882-1886 [Abstract] [Full Text]  
  • Lee, S. H., Kim, J. Y., Shin, S. H., An, Y. J., Choi, Y. W., Jung, Y. C., Jung, H. I., Sohn, E. S., Jeong, S. H., Lee, K. J. (2003). Dissemination of SHV-12 and Characterization of New AmpC-Type Beta-Lactamase Genes among Clinical Isolates of Enterobacter Species in Korea. J. Clin. Microbiol. 41: 2477-2482 [Abstract] [Full Text]  
  • Aibinu, I. E., Ohaegbulam, V. C., Adenipekun, E. A., Ogunsola, F. T., Odugbemi, T. O., Mee, B. J. (2003). Extended-Spectrum {beta}-Lactamase Enzymes in Clinical Isolates of Enterobacter Species from Lagos, Nigeria. J. Clin. Microbiol. 41: 2197-2200 [Abstract] [Full Text]  
  • Yigit, H., Anderson, G. J., Biddle, J. W., Steward, C. D., Rasheed, J. K., Valera, L. L., McGowan, J. E. Jr., Tenover, F. C. (2002). Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs. Antimicrob. Agents Chemother. 46: 3817-3822 [Abstract] [Full Text]  
  • Pradel, E., Pages, J.-M. (2002). The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46: 2640-2643 [Abstract] [Full Text]  
  • Arpin, C., Labia, R., Dubois, V., Noury, P., Souquet, M., Quentin, C. (2002). TEM-80, a Novel Inhibitor-Resistant {beta}-Lactamase in a Clinical Isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 46: 1183-1189 [Abstract] [Full Text]  
  • Kartali, G., Tzelepi, E., Pournaras, S., Kontopoulou, C., Kontos, F., Sofianou, D., Maniatis, A. N., Tsakris, A. (2002). Outbreak of Infections Caused by Enterobacter cloacae Producing the Integron-Associated {beta}-Lactamase IBC-1 in a Neonatal Intensive Care Unit of a Greek Hospital. Antimicrob. Agents Chemother. 46: 1577-1580 [Abstract] [Full Text]  
  • Canton, R., Oliver, A., Coque, T. M., Varela, M. d. C., Perez-Diaz, J. C., Baquero, F. (2002). Epidemiology of Extended-Spectrum {beta}-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period. J. Clin. Microbiol. 40: 1237-1243 [Abstract] [Full Text]  
  • Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., Carmeli, Y. (2001). Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp.. Antimicrob. Agents Chemother. 45: 2628-2630 [Abstract] [Full Text]  
  • De Gheldre, Y., Struelens, M. J., Glupczynski, Y., De Mol, P., Maes, N., Nonhoff, C., Chetoui, H., Sion, C., Ronveaux, O., Vaneechoutte, M. (2001). National Epidemiologic Surveys of Enterobacter aerogenes in Belgian Hospitals from 1996 to 1998. J. Clin. Microbiol. 39: 889-896 [Abstract] [Full Text]  
  • De Champs, C., Le Seaux, S., Dubost, J. J., Boisgard, S., Sauvezie, B., Sirot, J. (2000). Isolation of Pantoea agglomerans in Two Cases of Septic Monoarthritis after Plant Thorn and Wood Sliver Injuries. J. Clin. Microbiol. 38: 460-461 [Abstract] [Full Text]  
  • Osterblad, M., Pensala, O., Peterzens, M., Heleniusc, H., Huovinen, P. (1999). Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables. J Antimicrob Chemother 43: 503-509 [Abstract] [Full Text]  
  • Ko, W.-C., Wu, H.-M., Chang, T.-C., Yan, J.-J., Wu, J.-J. (1998). Inducible beta -Lactam Resistance in Aeromonas hydrophila: Therapeutic Challenge for Antimicrobial Therapy. J. Clin. Microbiol. 36: 3188-3192 [Abstract] [Full Text]  
  • Jalaluddin, S., Devaster, J.-M., Scheen, R., Gerard, M., Butzler, J.-P. (1998). Molecular Epidemiological Study of Nosocomial Enterobacter aerogenes Isolates in a Belgian Hospital. J. Clin. Microbiol. 36: 1846-1852 [Abstract] [Full Text]  
  • Pitout, J. D. D., Thomson, K. S., Hanson, N. D., Ehrhardt, A. F., Coudron, P., Sanders, C. C. (1998). Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenes Strains. Antimicrob. Agents Chemother. 42: 596-600 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»